Backlog Reached New High
Indium phosphide backlog exceeded $60.0 million, up from $49.0 million in the prior quarter (increase of >$11.0M, ~>22%), providing strong near- to medium-term revenue visibility.
Substantial Cash Raise Strengthens Balance Sheet
Cash, cash equivalents and investments increased by $97.2 million to $128.4 million as of 12/31/25, primarily from a public offering that generated approximately $93.9 million, providing funding for planned capacity expansion.
Clear Demand Drivers — AI / Data Center Growth
Company expects sequential revenue growth in Q1 driven by indium phosphide for AI/data center build-out; China data center–related revenue expected to grow by more than 60% in Q1 versus Q4.
Capacity Expansion Roadmap
AXT added ~25% capacity since the prior report and is on track to double capacity from Q4 2025 levels by end of 2026 (estimated run-rate ~ $35M/quarter); planned near-term CapEx for this phase ~ $30M, with potential further expansion in 2027 (additional $100–150M for greenfield).
Improved Profitability Trends Year-over-Year
Non-GAAP operating loss narrowed to $2.6M in Q4 2025 from $5.4M in Q4 2024 (improvement of $2.8M, ~52% improvement) and non-GAAP net loss improved to $2.6M from $4.2M year-over-year (~38% improvement).
Diversifying Customer Base and Product Mix
Winning broader indium phosphide customer set including Tier 1 laser and optical transceiver manufacturers (China and global); top 5 customers represented ~22.6% of revenue and no single customer >10%, indicating customer diversification.
Vertical Integration and Raw Materials Progress
Raw material joint venture revenue was $7.6M in Q4; subsidiary JinMei began refining high-quality indium, strengthening control of a critical material supply for indium phosphide substrates.
Q1 Near-Term Revenue Visibility
Management stated there is approximately $26M of revenue that can likely be recognized in Q1 (either already permitted to ship or not requiring export permits), with potential upside if additional permits are obtained.